NCT07800364

Brief Summary

The majority of lower limb fractures treated with surgery often leading to significant morbidity and mortality. Despite improvements in perioperative care, about 20% suffer from severe postoperative complications. So, effective perioperative pain management is crucial in this demographic to ensure optimal recovery and reduce complications. (1) Controlling the postoperative pain often begins in recovery room by using opioids, especially morphine. However, systemic opioids may develop many complications such as nausea and vomiting, apnea, respiratory depression, and urinary retention. To reduce the complications and consumption of the opioids, other procedures are recommended. One of these procedures is preemptive analgesia(2). In addition to pain, disrupted sleep quality is a common challenge, with evidence suggesting a bidirectional relationship where poor sleep exacerbates pain, and pain further disrupts sleep (3). Addressing both pain and sleep disturbances in the perioperative period is therefore critical for enhancing recovery and improving overall patient outcomes

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2026

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2026

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 2, 2026

Completed
Last Updated

September 2, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

August 29, 2026

Last Update Submit

August 29, 2026

Conditions

Keywords

Preoperative, Tizanidine,Pain

Outcome Measures

Primary Outcomes (2)

  • Time to first request of rescue analgesia

    24 hr

  • opioid consumption in 48 hrs postoperatively

    48hr

Study Arms (2)

tizanidine group

EXPERIMENTAL

tizanidine

Drug: Tizanidine

placebo group

PLACEBO COMPARATOR

placebo

Drug: Placebo

Interventions

oral administered preoperatively

tizanidine group

oral placebo adminstered preoperatively

placebo group

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged ≥ 21 years
  • Scheduled for lower limb orthopedic surgery
  • Able to provide informed consent

You may not qualify if:

  • History of hypersensitivity to tizanidine
  • Pregnancy or breastfeeding
  • Failure of spinal anesthesia or inadequate block.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

tanta University hospital

Tanta, Gharbia Governorate, Egypt

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativePain

Interventions

tizanidine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Central Study Contacts

Marwa Abogabal, Assistant professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Marwa Ahmed Abogabal

Study Record Dates

First Submitted

August 29, 2026

First Posted

September 2, 2026

Study Start

March 1, 2026

Primary Completion

September 1, 2026

Study Completion

September 1, 2026

Last Updated

September 2, 2026

Record last verified: 2026-03

Locations